Motor Neurone Disease Trial, Recruiting NCT07543367 Sponsor: Synchron, Inc. Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT07543367
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are able to give your agreement (consent) to take part in the study.
  • You have been diagnosed with ALS (also known as Lou Gehrig's disease) and have weakness in both arms.
  • Your ALS has not responded to treatment and you have had it for at least six months.
  • You are 22 years old or older.
  • Your doctors expect you to live for more than 12 months after the device is implanted.
  • A CT scan shows that a specific area of your brain (involved in movement) is in good enough condition for the study (confirm with trial site).
  • A CT scan of your blood vessels shows that your anatomy is suitable for the procedure (confirm with trial site).
  • Your body has a suitable area under the skin where a small device pouch can be created (confirm with trial site).
  • You are able to safely receive general anesthesia (be put to sleep for a procedure).
  • You are willing and able to attend all required clinic visits and training sessions, including some at home.
  • You have a caregiver who is willing and able to help with study visits — both at the clinic and at home — and assist with the device outside of visits (such as charging it).
  • Both you and your caregiver speak and understand English fluently.
  • Your home environment is suitable for brain-computer interface (BCI) training sessions.

Who may not be able to join:

  • You have an active infection or an unexplained fever in the 48 hours before signing up for the study.
  • You have a significant mental health condition that could affect your safety or ability to follow the study requirements, such as severe depression, psychosis, personality disorder, severe mood instability, or substance misuse.
  • You have been diagnosed with ALS combined with dementia (ALS-FTD) or any other form of dementia.
  • You already have an active implanted medical device, such as a pacemaker, deep brain stimulator, or similar device.
  • You have a known allergy to any of the materials used in the implanted device.
  • You cannot have certain types of imaging scans or a specific dye (contrast) used during those scans.
  • You have a history of blood clots in the large veins of the brain (central venous sinus thrombosis).
  • You have had a blood clot (such as a deep vein thrombosis or pulmonary embolism) in the past six months, have a history of repeated blood clots, or have a condition that makes your blood clot more easily than normal.
  • You cannot take blood-thinning medications for any reason.
  • You have a significantly increased risk of infection — for example, due to a weakened immune system, frequent or ongoing infections, or poorly controlled diabetes.
  • There is a significant risk that a surgical wound on your skin would not heal properly, such as a history of wounds that did not heal or poorly controlled diabetes.
  • You are currently pregnant or breastfeeding.
  • You are currently enrolled in another clinical trial that could affect the results or requirements of this study.
  • You have any other condition that could significantly affect your ability to participate — for example, vision or hearing problems that would make it difficult to use a computer screen or follow spoken instructions during training (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Synchron, Inc.
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Device-related serious adverse events up to 180 days after implant

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov